You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aluminum Hydroxide And Magnesium Trisilicate patents expire, and when can generic versions of Aluminum Hydroxide And Magnesium Trisilicate launch?

Aluminum Hydroxide And Magnesium Trisilicate is a drug marketed by Pennex and is included in one NDA.

The generic ingredient in ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE is aluminum hydroxide; magnesium trisilicate. There are one hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE?
  • What are the global sales for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE?
  • What is Average Wholesale Price for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE?
Summary for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE
Drug patent expirations by year for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE

US Patents and Regulatory Information for ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pennex ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 089449-001 Nov 27, 1987 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Aluminum Hydroxide and Magnesium Trisilicate

Introduction

Aluminum hydroxide and magnesium trisilicate, commonly known as antacids, are widely used to treat heartburn, acid indigestion, and other conditions caused by excessive stomach acid. This combination medicine is available under various brand names, including Gaviscon, and plays a significant role in the pharmaceutical and healthcare industries.

Market Size and Growth

The market for aluminum hydroxide and magnesium trisilicate is closely tied to the broader antacids market and the magnesium trisilicate market. As of 2023, the magnesium trisilicate market was valued at USD 1.2 billion and is projected to reach USD 1.8 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.5% from 2024 to 2031[1].

Key Applications

Pharmaceuticals

Aluminum hydroxide and magnesium trisilicate are primarily used in the pharmaceutical sector as antacids to treat gastric hyperacidity, heartburn, and acid indigestion. Their ability to lower the acidity of stomach acid makes them essential components in medications like Gaviscon Regular Strength Tablets[2][3][5].

Other Industries

In addition to pharmaceuticals, magnesium trisilicate is used in various other industries:

  • Cosmetics: It is used in skincare products to stabilize formulations and enhance texture.
  • Food Additives: It serves as a clarifying agent and thickening agent in food products.
  • Industrial Applications: It is utilized in different industrial processes due to its versatile properties[1][4].

Market Drivers

Several factors drive the growth of the aluminum hydroxide and magnesium trisilicate market:

Increasing Incidence of Gastrointestinal Issues

The rising frequency of gastrointestinal problems, such as heartburn and acid indigestion, increases the demand for antacids containing aluminum hydroxide and magnesium trisilicate[1][2][5].

Technological Advancements

Improvements in manufacturing methods have enhanced the production efficiency and application diversity of magnesium trisilicate, contributing to market growth[1].

Consumer Awareness and Health Trends

Growing consumer awareness of wellness and health, including the use of dietary supplements containing magnesium, further boosts the market. The preference for natural and eco-friendly ingredients also supports the expansion of this market[1][4].

Regulatory Support

Supportive regulations for agricultural and pharmaceutical uses of magnesium trisilicate also contribute to the market's upward trajectory[1].

Geographical Segmentation

The market for aluminum hydroxide and magnesium trisilicate is segmented geographically into regions such as North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The Asia-Pacific region is expected to be a significant growth driver due to its large population and increasing healthcare needs[1].

Competitive Landscape

The market is characterized by the presence of several key players, including Pfizer, Merck, TCI Chemicals, Hovione, and others. These companies are profiled based on the types of products they offer and various market-related factors. The competitive landscape is dynamic, with companies continuously innovating and expanding their product portfolios[1].

Product Forms and Dosages

Aluminum hydroxide and magnesium trisilicate are available in various dosage forms, primarily as chewable tablets. The typical dosage for treating gastric hyperacidity and heartburn involves chewing 2-4 tablets orally every 6 hours as needed, not exceeding 16 tablets per day[2][3][5].

Side Effects and Precautions

While these medications are generally safe, they can cause side effects such as constipation, diarrhea, nausea, and vomiting. Severe interactions with other drugs, such as raltegravir and atazanavir, must be considered. Caution is advised in patients with renal failure, those on a low-salt diet, and during pregnancy and breastfeeding[2][3][5].

Financial Projections

Given the growth drivers and market dynamics, the financial trajectory for aluminum hydroxide and magnesium trisilicate is positive. The magnesium trisilicate market, in particular, is expected to grow from USD 1.2 billion in 2023 to USD 1.8 billion by 2031, indicating a stable and increasing demand for these products[1].

Key Takeaways

  • The market for aluminum hydroxide and magnesium trisilicate is driven by increasing gastrointestinal issues, technological advancements, and consumer health trends.
  • The market is segmented by application, product form, and geography, with Asia-Pacific being a significant growth region.
  • Key players are innovating and expanding their product portfolios to meet growing demand.
  • The financial trajectory is positive, with the magnesium trisilicate market expected to reach USD 1.8 billion by 2031.

FAQs

What are the primary uses of aluminum hydroxide and magnesium trisilicate?

Aluminum hydroxide and magnesium trisilicate are primarily used to treat heartburn, acid indigestion, and other conditions caused by excessive stomach acid.

What are the common side effects of aluminum hydroxide and magnesium trisilicate?

Common side effects include constipation, diarrhea, nausea, vomiting, and in severe cases, aluminum intoxication or low blood magnesium levels.

Which industries besides pharmaceuticals use magnesium trisilicate?

Magnesium trisilicate is used in the cosmetics industry for skincare products, in food products as a clarifying agent, and in various industrial applications.

What is the expected growth rate of the magnesium trisilicate market?

The magnesium trisilicate market is expected to grow at a CAGR of 4.5% from 2024 to 2031.

Who are some of the key players in the magnesium trisilicate market?

Key players include Pfizer, Merck, TCI Chemicals, Hovione, and other prominent companies in the pharmaceutical and chemical industries.

Cited Sources:

  1. Market Research Intellect, "Magnesium Trisilicate Market Size, Share, Growth & Trends [2024 - 2031]".
  2. RxList, "Aluminum Hydroxide/Magnesium Trisilicate: Side Effects, Dosages, Treatment, Interactions, Warnings".
  3. Drugs.com, "Aluminum hydroxide and magnesium trisilicate".
  4. Market Research Intellect, "Magnesium Aluminum Silicate Market Size and Projections".
  5. Cleveland Clinic, "Aluminum Hydroxide; Magnesium Trisilicate chewable tablets".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.